Eli Lilly's Q3 performance exceeded expectations but lowered its annual profit guidance due to a surge in revenue from "weight loss pills". Prior to Thursday's trading session, American pharmaceutical company Eli Lilly released its third quarter financial report. Although the company's Q3 revenue and profit exceeded expectations, it lowered its annual profit guidance.